| abstract |
Formula I, i.e. [Formula I] Compounds of, along with their polymorphs, stereoisomers, tautomers, prodrugs, solvates, and pharmaceutically acceptable salts thereof, are described herein. The compounds described herein, polymorphs, stereoisomers, tautomers, prodrugs, solvates and pharmaceutically acceptable salts thereof, are bicyclic compounds that are inhibitors of PD-1/PD-L1 interaction/activation. |